Introduction
Materials and methods
Study design and patient selection
Statistical analysis
Results
Study population
Population characteristics
Variable | All patients (N = 311,239) | Tumor location | ||
---|---|---|---|---|
Left (N = 177,444) | Right (N = 133,795) | P value | ||
Sex, no. (%) | < 0.001 | |||
Male | 163,727 (52.6) | 101,262 (57.1) | 62,465 (46.7) | |
Female | 147,512 (47.4) | 76,182 (42.9) | 71,330 (53.3) | |
Age, years, no. (%) | < 0.001 | |||
≤ 44 years | 16,432 (5.3) | 11,995 (6.8) | 4437 (3.3) | |
45–59 years | 75,976 (24.4) | 53,512 (30.2) | 22,464 (16.8) | |
60–74 years | 114,888 (36.9) | 66,021 (37.2) | 48,867 (36.5) | |
≥ 75 years | 103,943 (33.4) | 45,916 (25.9) | 58,027 (43.4) | |
Marital status, no. (%) | < 0.001 | |||
Unmarried | 164,833 (53.0) | 96,583 (54.4) | 68,250 (51.0) | |
Married | 129,553 (41.6) | 70,651 (39.8) | 58,902 (44.0) | |
Unknown | 16,853 (5.4) | 10,210 (5.8) | 6643 (5.0) | |
Race, no. (%) | < 0.001 | |||
White | 246,763 (79.3) | 139,135 (78.4) | 107,628 (80.4) | |
Black | 36,141 (11.6) | 18,935 (10.7) | 17,206 (12.9) | |
AI/A | 2195 (0.7) | 1369 (0.8) | 826 (0.6) | |
A/PI | 24,495 (7.9) | 16,809 (9.5) | 7686 (5.7) | |
Unknown | 1645 (0.5) | 1196 (0.7) | 449 (0.3) | |
T, no. (%) | < 0.001 | |||
T0 | 98 (0.0) | 80 (0.0) | 18 (0.0) | |
Tis | 11,890 (3.8) | 7983 (4.5) | 3827 (2.9) | |
T1 | 55,876 (18.0) | 37,179 (21.0) | 18,697 (14.0) | |
T2 | 41,049 (13.2) | 22,469 (12.7) | 18,580 (13.9) | |
T3 | 146,422 (47.0) | 79,545 (44.8) | 66,877 (50.0) | |
T4 | 42,837 (13.8) | 21,753 (12.3) | 21,084 (15.8) | |
Tx | 13,147 (4.2) | 8435 (4.8) | 4712 (3.5) | |
N, no. (%) | < 0.001 | |||
N0 | 186,803 (60.0) | 106,617 (60.1) | 80,186 (59.9) | |
N1 | 73,582 (23.6) | 43,341 (24.4) | 30,241 (22.6) | |
N2 | 43,440 (14.0) | 22,609 (12.7) | 20,831 (15.6) | |
NX | 7414 (2.4) | 4877 (2.7) | 2537 (1.9) | |
M, no. (%) | < 0.001 | |||
M0 | 253,131 (81.3) | 143,087 (80.6) | 110,044 (82.2) | |
M1 | 57,843 (18.6) | 34,167 (19.3) | 23,676 (17.7) | |
MX | 265 (0.1) | 190 (0.1) | 75 (0.1) | |
Stage, no. (%) | < 0.001 | |||
0 | 11,810 (3.8) | 7983 (4.5) | 3827 (2.9) | |
I | 78,036 (25.1) | 47,234 (26.6) | 30,802 (23.0) | |
II | 80,267 (25.8) | 40,434 (22.8) | 39,833 (29.8) | |
III | 83,283 (26.8) | 47,626 (26.8) | 35,657 (26.7) | |
IV | 57,843 (18.6) | 34,167 (19.3) | 23,676 (17.7) | |
Histology, no. (%) | < 0.001 | |||
Adenocarcinoma | 284,725 (91.5) | 167,261 (94.3) | 117,464 (87.8) | |
AM/MPA | 23,282 (7.5) | 8869 (5.0) | 14,413 (10.8) | |
SRCC | 3232 (1.0) | 1314 (0.7) | 1918 (1.4) | |
Grade, no. (%) | < 0.001 | |||
I | 25,611 (8.2) | 14,955 (8.4) | 10,656 (8.0) | |
II | 201,082 (64.6) | 117,591 (66.3) | 83,491 (62.4) | |
III | 46,222 (14.9) | 20,411 (11.5) | 25,811 (19.3) | |
IV | 6550 (2.1) | 2539 (1.4) | 4011 (3.0) | |
Unknown | 31,774 (10.2) | 21,948 (12.4) | 9826 (7.3) |
Factors correlated with survival
Covariate | Total no. | OS rate (%) | Multivariable analysis | |
---|---|---|---|---|
Hazard ratio (95% CI) | P value | |||
Sex | ||||
Male | 130,934 | 57.5 | 1 [Reference] | |
Female | 117,927 | 58.7 | 0.952 (0.937–0.967) | < 0.001 |
Age, years | ||||
≤ 44 years | 15,306 | 65.8 | 1 [Reference] | |
45–59 years | 68,210 | 67.8 | 0.914 (0.881–0.948) | < 0.001 |
60–74 years | 92,659 | 62.7 | 1.145 (1.104–1.186) | < 0.001 |
≥ 75 years | 72,686 | 42.2 | 2.635 (2.541–2.733) | < 0.001 |
Marital status | ||||
Married | 132,569 | 63.7 | 1 [Reference] | |
Unmarried | 103,050 | 50.2 | 1.741 (1.712–1.770) | < 0.001 |
Unknown | 13,242 | 62.9 | 1.035 (0.997–1.074) | .068 |
Stage | ||||
0 | 8930 | 80.2 | 1 [Reference] | |
I | 59,442 | 77.9 | 1.149 (1.087–1.215) | < 0.001 |
II | 63,647 | 68.9 | 1.828 (1.731–1.931) | < 0.001 |
III | 68,555 | 60.2 | 2.678 (2.537–2.827) | < 0.001 |
IV | 48,287 | 11.3 | 31.795 (29.968–33.733) | < 0.001 |
Histology | ||||
Adenocarcinoma | 228,381 | 58.9 | 1 [Reference] | |
AM/MPA | 17,989 | 52.1 | 1.318 (1.278–1.358) | < 0.001 |
SRCC | 2491 | 27.7 | 3.740 (3.425–4.085) | < 0.001 |
Grade | ||||
I | 20,358 | 70.0 | 1 [Reference] | |
II | 161,834 | 61.3 | 1.473 (1.427–1.520) | < 0.001 |
III | 36,654 | 44.8 | 2.875 (2.772–2.981) | < 0.001 |
IV | 5107 | 45.0 | 2.852 (2.678–3.037) | < 0.001 |
Unknown | 24,908 | 49.9 | 2.343 (2.253–2.436) | < 0.001 |
Site | ||||
Left | 145,885 | 60.2 | 1 [Reference] | |
Right | 102,976 | 55.1 | 1.233 (1.213–1.253) | < 0.001 |
Exploratory analyses of the associations between PTL and survival
Stage | Primary tumor location | |||||
---|---|---|---|---|---|---|
Left | Right | Cox regression | ||||
Total no. | OS (%) | Total no. | OS (%) | Right vs. left, HR (95) CI % | P value | |
0–IV | 145,885 | 60.2 | 102,976 | 55.1 | 1.224 (1.208–1.241) | < 0.001 |
0 | 6220 | 81.7 | 2710 | 76.7 | 1.306 (1.171–1.457) | < 0.001 |
I | 37,166 | 79.6 | 22,276 | 75.2 | 1.269 (1.220–1.319) | < 0.001 |
II | 32,899 | 69.3 | 30,748 | 68.5 | 1.042 (1.009–1.075) | .011 |
III | 40,592 | 64.4 | 27,963 | 54.0 | 1.501 (1.461–1.542) | < 0.001 |
IV | 29,008 | 13.0 | 19,279 | 8.7 | 1.356 (1.328–1.385) | < 0.001 |